Navigation Links
Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
Date:5/1/2012

ities

(33,921)

(13,271)FINANCING ACTIVITIES:Purchase of common stock, net of issuance of common stock from treasury

(31,588)

(17,552)Distributions to noncontrolling interests

(13,120)

(12,627)Principal payments on Term Loans, net of proceeds

(219,063)

(4,197)Exercise of Endo Pharmaceuticals Holdings Inc. stock options

9,543

12,417Other

2,106

3,120Net cash used in financing activities

(252,122)

(18,839)Effect of foreign exchange rate

(212)

—NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

(299,317)

98,948CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

547,620

466,214CASH AND CASH EQUIVALENTS, END OF PERIOD

$
248,303

$
565,162Safe Harbor StatementThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements.  Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" in our Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein or therein, could affect our future financial results and could cause our actual results to differ materially from those expressed in forward-looking statements contained in our Annual Report on Form 10-K. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause our actu
'/>"/>

SOURCE Endo
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Hospira Reports First-Quarter 2012 Results
2. Luminex Corporation Reports First Quarter 2012 Results
3. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
4. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
8. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
9. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
10. Cepheid Reports 2012 First Quarter Results
11. Sotera Wireless Reports FDA Clearance of ViSi Mobile™ System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... , May 18, 2013 Faruqi ... firm, is investigating potential securities fraud at AVEO ... (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... and its executives violated federal securities laws by ... Company,s Phase III drug trials for Tivopath (tivozanib) ...
(Date:5/17/2013)... , May 17, 2013  Orexigen® Therapeutics, Inc. (Nasdaq: ... company overview at the UBS Global Healthcare Conference in ... Wednesday, May 22 nd at 11 a.m. Eastern Time. ... the presentation, please visit the Investor Relations section of the ... be available for 14 days after the event. ...
(Date:5/17/2013)... YORK , May 17, 2013 /PRNewswire-iReach/ -- United ... Advanced Cardiac Life Support (ACLS), Pediatric Advanced Life Support ... free PALS, BLS and ACLS online course ... manuals, people simply need to build an account with ... materials for these programs, United Medical Education is setting ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2
... BETHESDA, Md., April 14 Micromet, Inc.,(Nasdaq: ... novel, proprietary,antibodies for the treatment of cancer, ... meeting of the American Association for,Cancer Research ... that commercial,anti-cancer antibodies trastuzumab (Herceptin(R); Genentech, Roche),cetuximab ...
... the, Tumor Suppressor P53 Inhibited Tumor Growth Synergistically in Preclinical ... ... 14 ,Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) announced today that ... 2008 Annual Meeting of the American Association for Cancer Research,(AACR) further ...
Cached Medicine Technology:Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 2Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 3Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 4Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 5Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrine's anti-PS Vascular Targeting Antibodies 2Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrine's anti-PS Vascular Targeting Antibodies 3Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrine's anti-PS Vascular Targeting Antibodies 4
(Date:5/18/2013)... HealthDay Reporter , , FRIDAY, May 17 (HealthDay News) -- ... of what is considered the "bible" of modern psychiatry ... "This is unprecedented, the amount of commentary and ... the American Psychiatric Association (APA). "It,s been an interesting ... have to evaluate it and then make your own ...
(Date:5/18/2013)... Orlando, FL (May 18, 2013) There are ... procedures commonly used to diagnose or treat gastrointestinal ... Week (DDW). , A study by New ... that more objective testing may substantially reduce the ... (GERD). Although GERD is believed to affect nearly ...
(Date:5/18/2013)... 18, 2013 Today, Zane Benefits, ... agents’ role in Marketplaces . Zane Benefits, which ... sponsored health benefits, is the leader in health ... health reimbursement arrangements . , According to Zane ... Services (HHS) recently released a much-anticipated statement and ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 After working diligently ... SizeItUp formally announced the integration of the fitment ... Hyundai Genesis is set to stun the automobile market with ... 2012 Hyundai Genesis is marked as the latest entry in ... the vehicles lined up for the year 2013. , ...
(Date:5/18/2013)... Although obesity is associated with an increased risk ... esophageal adenocarcinoma, a type of esophageal cancer, is stronger ... on Cancer.gov, last reviewed in January 2012, overweight ... those of normal and healthy weight to develop this ... cancer is not well understood, it is now thought ...
Breaking Medicine News(10 mins):Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 2Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 3Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 4Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3
... NY - In an important finding published online in ... of Medicine of Yeshiva University, along with collaborators at ... responsible for causing breast cancer to spread. , ... tumor travel to distant sites via the blood system. ...
... to identify a disease whether it is common ... people think the condition is, according to new research ... study on how people understand and interpret disease. ... Public Library of Science: ONE , examined many recently ...
... to Phase 3 trials following the successful trial of the ... Korogwe, Tanzania and coastal Kenya, which is reported today in ... , In a separate paper, which also appears in the ... co-administration of the RTS, S/AS02 malaria vaccine through the WHO ...
... , ... (Vocus) December 8, 2008 -- Losing a child to the ... , it is a tragedy they have experienced firsthand. The nonprofit organization ... the flu or have had a child experience severe medical complications from ...
... WASHINGTON, Dec. 8 The independent, non-profit, ... medical records for every doctor,s office and hospital ... key elements of which were announced as part ... Address ( http://change.gov/newsroom/entry/the_key_parts_of_the_jobs_plan/ ). , ...
... saves hospitals time, increases accuracy of medication supply, and ... , ORLANDO, Fla., Dec. 8 ... solutions for hospital supply chain logistics, announced today at ... that it has developed a patent-pending replenishment solution for ...
Cached Medicine News:Health News:Einstein researchers discover protein that contributes to cancer spread 2Health News:Einstein researchers discover protein that contributes to cancer spread 3Health News:Medical terms worry more people than lay terms, study finds 2Health News:Promising trials of malaria vaccine lead to calls for Phase 3 development 2Health News:Promising trials of malaria vaccine lead to calls for Phase 3 development 3Health News:For Kids, the Flu Can Be Severe, Even Deadly 2Health News:For Kids, the Flu Can Be Severe, Even Deadly 3Health News:eHealth Initiative Applaudes President-Elect Obama's Recognition of the Importance of Information Technology to Improve U.S. Health Care System 2Health News:Aethon Develops First-Ever Solution for Automated Replenishment of Pharmacy ADCs 2Health News:Aethon Develops First-Ever Solution for Automated Replenishment of Pharmacy ADCs 3
... The Brasseler USA™ Battery Packs contain ... age have a great impact upon battery ... is necessary. Any deviation from these recommendations ... are sensitive to heat. Any exposure of ...
... Brasseler USA™ Battery Packs contain rechargeable nickel ... a great impact upon battery life. Strict ... Any deviation from these recommendations will shorten ... to heat. Any exposure of the Battery ...
Pneumatic High-speed Drill, 90k Rpm, With Microaire Hose Connector....
... powered system, offers precision with ease ... procedures. The system can be utilized ... oral, maxillofacial, podiatric and otology techniques. ... a high speed drill, low speed ...
Medicine Products: